Intake of copper has no effect on cognition in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial

Disturbed copper (Cu) homeostasis may be associated with the pathological processes in Alzheimer’s disease (AD). In the present report, we evaluated the efficacy of oral Cu supplementation in the treatment of AD in a prospective, randomized, double-blind, placebo-controlled phase 2 clinical trial in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kessler, Holger, Bayer, Thomas A., Bach, Daniela, Schneider-Axmann, Thomas, Supprian, Tillmann, Herrmann, Wolfgang, Haber, Manfred, Multhaup, Gerd, Falkai, Peter, Pajonk, Frank-Gerald
Formato: Texto
Lenguaje:English
Publicado: Springer Vienna 2008
Materias:
Alzheimer's Disease and Related Disorders - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516533/
https://www.ncbi.nlm.nih.gov/pubmed/18587525
http://dx.doi.org/10.1007/s00702-008-0080-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516533/
https://www.ncbi.nlm.nih.gov/pubmed/18587525
http://dx.doi.org/10.1007/s00702-008-0080-1

Ejemplares similares